Publications of Tiago Fleming Outeiro
All genres
Journal Article (133)
61.
Journal Article
23, 174 (2023)
Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer 62.
Journal Article
177, 105995 (2023)
The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease 63.
Journal Article
11 (8), 2209 (2023)
Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis. Biomedicines 64.
Journal Article
11 (2), 505 (2023)
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines 65.
Journal Article
38 (2), pp. 162 - 177 (2022)
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders 66.
Journal Article
12, pp. 2397 - 2422 (2022)
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease: JPD 67.
Journal Article
11 (22), 3673 (2022)
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 68.
Journal Article
269, 104721 (2022)
Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics 69.
Journal Article
Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry (2022)
70.
Journal Article
10 (1), 98 (2022)
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 71.
Journal Article
168, 105696 (2022)
Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 72.
Journal Article
37 (1), pp. 39 - 51 (2022)
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo. Movement Disorders 73.
Journal Article
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 74.
Journal Article
87, pp. 70 - 85 (2021)
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. NeuroToxicology 75.
Journal Article
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
76.
Journal Article
404, pp. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 77.
Journal Article
116 (51), pp. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 78.
Journal Article
28, pp. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 79.
Journal Article
47, pp. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 80.
Journal Article
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration